Addressing modifiable barriers such as medication copays may improve access to care and outcomes for patients with heart failure with reduced ejection fraction (HFrEF), according to a cohort study published April 1 in JAMA Cardiology, which identified significant gaps in the rate and timeliness of quadruple therapy for veterans who are newly diagnosed. Read more.